Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) Invested Capital: 2010-2024

Historic Invested Capital for Cryo Cell International (CCEL) over the last 15 years, with FY2024 value amounting to -$9.7 million.

  • Cryo Cell International's Invested Capital fell 5854.74% to -$11.6 million in Q3 2025 from the same period last year, while for Aug 2025 it was -$11.6 million, marking a year-over-year decrease of 5854.74%. This contributed to the annual value of -$9.7 million for FY2024, which is 114.68% up from last year.
  • As of FY2024, Cryo Cell International's Invested Capital stood at -$9.7 million, which was up 114.68% from -$9.8 million recorded in FY2023.
  • In the past 5 years, Cryo Cell International's Invested Capital registered a high of $4.2 million during FY2021, and its lowest value of -$9.8 million during FY2023.
  • For the 5-year period, Cryo Cell International's Invested Capital averaged around -$3.4 million, with its median value being -$2.7 million (2020).
  • In the last 5 years, Cryo Cell International's Invested Capital surged by 25700.2% in 2021 and then tumbled by 141055.09% in 2023.
  • Annual analysis of 5 years shows Cryo Cell International's Invested Capital stood at -$2.7 million in 2020, then skyrocketed by 257.0% to $4.2 million in 2021, then crashed by 82.11% to $748426.0 in 2022, then crashed by 1410.55% to -$9.8 million in 2023, then rose by 1.15% to -$9.7 million in 2024.
  • Its last three reported values are -$9.7 million in FY2024, -$9.8 million for FY2023, and $748426.0 during FY2022.